ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | -97.7% | 27,100 | -65.5% | 0.00% | -100.0% |
| Q4 2022 | $43 | -99.8% | 78,500 | +28.7% | 0.00% | +100.0% |
| Q3 2022 | $21,000 | +31.2% | 61,000 | +20.1% | 0.00% | +100.0% |
| Q2 2022 | $16,000 | -20.0% | 50,800 | -5.2% | 0.00% | – |
| Q1 2022 | $20,000 | -67.2% | 53,600 | -48.5% | 0.00% | -100.0% |
| Q4 2021 | $61,000 | -22.8% | 104,000 | +26.4% | 0.00% | 0.0% |
| Q3 2021 | $79,000 | +23.4% | 82,300 | +4.7% | 0.00% | 0.0% |
| Q2 2021 | $64,000 | -7.2% | 78,600 | -22.6% | 0.00% | -33.3% |
| Q1 2021 | $69,000 | +430.8% | 101,500 | -3.4% | 0.00% | – |
| Q4 2020 | $13,000 | -65.8% | 105,100 | +3.4% | 0.00% | -100.0% |
| Q3 2020 | $38,000 | +850.0% | 101,600 | +204.2% | 0.00% | – |
| Q2 2020 | $4,000 | – | 33,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |